HOME >> BIOLOGY >> NEWS
Newly Identified Molecular Mechanism Could Lead To New Approaches For Preventing,,Heart Attack, Stroke

UC San Francisco researchers have identified a molecular mechanism that may play an important role in activating platelets, the blood cells that coagulate to stop bleeding but also cause the clots leading to heart attack and stroke. The finding, published in the August 13 issue of Nature, requires further investigation, said the senior author of the study, Shaun R. Coughlin, MD, PhD, director of the Cardiovascular Research Institute (CRVI) and professor of medicine and cellular and molecular pharmacology at UCSF, but it could provide a new avenue for developing drugs for preventing heart attack and stroke.

The study, conducted in mice and on human platelets, explored the way in which the enzyme known as thrombin, one of several factors known to activate platelets, stimulates the blood cells into action. The initial observations in mice led the researchers to a potentially profound finding for humans.

In the mouse study, the researchers determined that thrombin is able to activate platelets by latching onto, and cleaving, a newly identified receptor in the membrane of the cells. When the enzyme (a protease) binds to the receptor, it instigates the transmembrane signaling that prompts platelet aggregation. The researchers named the receptor protease activated receptor (PAR) 4.

The investigators had previously identified a PAR in human platelets, which they named PAR1. They also had previously identified a PAR in mouse platelets, which they named PAR3.

In the current study, they created a mouse model with platelets lacking PAR3 and found that while the mice had a markedly delayed and diminished response to thrombin activation the response was not totally absent. The discovery of PAR4 explained the continued response. "We determined that PAR3 is necessary for normal thrombin responses in mouse platelets, but that PAR4 does contribute to thrombin signaling," said Coughlin.

The discovery that PAR3 and PAR4 appear to act as a dual-receptor syst
'"/>

Contact: Jennifer O'Brien
jobrien@itsa.ucsf.edu
(415) 476-2557
University of California - San Francisco
12-Aug-1998


Page: 1 2 3

Related biology news :

1. Newly identified master gene key in babys first breath
2. Newly discovered protein may be key to muscular dystrophy
3. Newly designed nanoparticle quantum dots simultaneously target and image prostate tumors in mice
4. Newly grown kidneys can sustain life in rats
5. Newly discovered gene controls levels of bad cholesterol in mice
6. Newly identified gene linked to brain development
7. Newly cloned gene key to global adaptation of wheat
8. Newly identified genes may help predict outcome in childhood leukemia
9. Newly identified gene may halt fuzzy, moldy fruit
10. Newly found gene resistant to economically crippling wheat disease
11. Newly invented Endometrial Function Test (EFT®) solves the puzzle of unexplained infertility

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/7/2018)... ... September 06, 2018 , ... Sensors Midwest ... show Sensors Expo & Conference , announces their partnership with Fraunhofer USA ... an IoT Enabled Industrial IoT Certification Program. Taking place on October 17, 2018 ...
(Date:9/1/2018)... ... August 31, 2018 , ... Right this minute, Frenchman Ben Lecomte is hard at work on ... 1998, he’s taken on a new challenge: going from Tokyo to San Francisco, churning his ... team on the support boat. As the first expedition of its kind, The Swim is ...
(Date:8/31/2018)... ... 30, 2018 , ... CallTower is pleased to announce Jason Ulm, ... telecommunications experience and over ten years in executive leadership. Prior to joining CallTower, Jason ... early 2018. , In this new role, Jason will manage CallTower’s ...
Breaking Biology News(10 mins):
(Date:9/12/2018)... VIENNA, Austria (PRWEB) , ... September 10, 2018 , ... ... of Semantic Graph Database technology, AllegroGraph , for Knowledge Graphs, and Semantic ... of Semantic AI solutions, today announced a partnership to develop the Noam Chomsky ...
(Date:9/12/2018)... (PRWEB) , ... September 12, 2018 , ... ... Bronich-Hall, a quality management professional and former Senior Director of Regulatory Affairs and ... , As Senior Director of Regulatory Affairs and Quality Systems at WellDoc, ...
(Date:9/7/2018)... ... September 06, 2018 , ... ... commercialization, is releasing the agenda for its upcoming user conference. , This ... discussing the latest challenges, opportunities, and approaches to regulatory compliance and quality management. ...
(Date:9/1/2018)... (PRWEB) , ... August 31, 2018 , ... ... research results of the impact of a proprietary biofield energy treated nutraceutical supplement ... assessed biomarkers for immune function response and blood, as well as, organ-specific inflammation. ...
Breaking Biology Technology:
Cached News: